CD274 and non-small cell lung carcinoma: However, immunohistochemical and mRNA expression profiling analysis of EGFRm NSCLC patient tumor samples demonstrated decreased PD-L1 expression across multiple datasets (89, 90), leading to an unresolved discrepancy between preclinical and clinical studies.